Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide linker and combination for prodrugs activated by prostate-specific antigen

Peptide linker and combination for prodrugs activated by prostate-specific antigen

US Patent 11628221 · Granted Apr 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cystine diamide analogs for the prevention of cystine stone formation in cystinu2025
Small molecule direct inhibitors of KEAP1-NRF2 protein-protein interaction2024
Cystine diamide analogs for the prevention of cystine stone formation in cystinu2022
Peptide-linked ester prodrugs activated by prostate-specific antigen2021
Peptide-linked ester prodrugs activated by prostate-specific antigen2021
Cystine diamide analogs for the prevention of cystine stone formation in cystinu2020
Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulato2018
Cystine diamide analogs for the prevention of cystine stone formation in cystinu2016
HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interaction2015
Chemotherapeutic conjugates and methods of use2013